Should new drugs be used without outcome data? Implications of Allhat and Elite II.
Kaplan
N M
NM
University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8899, USA.
D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000379:methods*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D000804:Angiotensin II